Literature DB >> 9546732

Expression of intercellular adhesion molecule-1 messenger ribonucleic acid and protein in human term placental cells and its modulation by pro-inflammatory cytokines (interleukin-1beta and tumor necrosis factor alpha).

B Gaffuri1, P Vigano, A Nozza, G Gornati, A M Di Blasio, M Vignali.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) is a ligand for the integrins lymphocyte function-associated antigen-1 (LFA-1) and complement receptor-3 (Mac-1), making it an important participant in many immune and inflammatory processes. Previous studies suggested that lack or reduced expression of ICAM-1 on trophoblast might partially explain its resistance to lysis by cytotoxic effectors. However, whether or not the adhesion molecule is expressed on placental cells is still a matter of debate. In this study, we determined ICAM-1 expression at mRNA, surface, and soluble protein levels on human trophoblasts throughout their functional differentiation in culture from cytotrophoblasts into syncytiotrophoblasts. Placental cells were obtained from 6 term placentas derived from normal pregnancies. ICAM-1 mRNA was detected by reverse transcription-polymerase chain reaction using two oligonucleotide primers specific for the human ICAM-1 gene. A single major DNA band of the expected size (943 base pairs) was obtained in both cytotrophoblasts and syncytiotrophoblasts. Flow cytometric analysis demonstrated expression of surface ICAM-1 protein on 45.5+/-3.5% of cytotrophoblasts. No changes were observed during differentiation in culture. Levels of the soluble form of ICAM-1 (sICAM-1) released by placental cells were undetectable when assessed by a specific ELISA. Finally, we investigated the effect of pro-inflammatory cytokines on placental ICAM-1 expression. Treatment of cultured trophoblasts for 24 h with interleukin-1beta (1 ng/ml) or tumor necrosis factor alpha (1 ng/ml) increased surface expression of ICAM-1 without inducing sICAM-1 shedding. However, on placental cells, the two cytokines exerted stimulatory effects lower than those detected on endometrial cells used as positive control. These observations document that the ICAM-1 gene is expressed in both cytotrophoblasts and syncytiotrophoblasts, suggesting that the molecule may be of value for some immune-mediated processes. On the other hand, the low sensitivity of trophoblasts to cytokine-mediated induction of ICAM-1 expression might represent a functional mechanism contributing to maternal tolerance for fetal graft.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546732     DOI: 10.1095/biolreprod58.4.1003

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

Review 1.  The Involvement of Cell Adhesion Molecules, Tight Junctions, and Gap Junctions in Human Placentation.

Authors:  Enoch Appiah Adu-Gyamfi; Armin Czika; Philip Narteh Gorleku; Amin Ullah; Zulqarnain Panhwar; Ling-Ling Ruan; Yu-Bin Ding; Ying-Xiong Wang
Journal:  Reprod Sci       Date:  2020-11-04       Impact factor: 3.060

2.  The value of the soluable intercellular adhesion molecule-1 levels in matermal serum for determination of occult chorioamnionitis in premature rupture of membranes.

Authors:  Li Zou; Huijun Zhang; Jianfang Zhu; Jianwen Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 3.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

4.  Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells.

Authors:  Andrea Balduit; Alessandro Mangogna; Chiara Agostinis; Gabriella Zito; Federico Romano; Giuseppe Ricci; Roberta Bulla
Journal:  Nutrients       Date:  2020-06-18       Impact factor: 5.717

5.  Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia.

Authors:  Shin-Young Kim; Hyun-Mee Ryu; Jae Hyug Yang; Moon-Young Kim; Hyun-Kyong Ahn; Ha-Jung Lim; Joong-Sik Shin; Hyuk-Jun Woo; So-Yeon Park; Young-Mi Kim; Jin-Woo Kim; Eun Hee Cho
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.